These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23313887)

  • 41. Heterosubtypic protection against influenza A induced by adenylate cyclase toxoids delivering conserved HA2 subunit of hemagglutinin.
    Staneková Z; Adkins I; Kosová M; Janulíková J; Sebo P; Varečková E
    Antiviral Res; 2013 Jan; 97(1):24-35. PubMed ID: 23036818
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses.
    Johnson PA; Conway MA; Daly J; Nicolson C; Robertson J; Mills KH
    J Gen Virol; 2000 Jul; 81(Pt 7):1737-45. PubMed ID: 10859379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults.
    Treanor JJ; Schiff GM; Couch RB; Cate TR; Brady RC; Hay CM; Wolff M; She D; Cox MM
    J Infect Dis; 2006 May; 193(9):1223-8. PubMed ID: 16586358
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Construction of baculovirus vector with WPRE regulatory element to express Newcastle disease virus F gene in primary chicken embryo cells].
    Gao D; Ping W; Jin L; Shen W; Song G; Tang X; An Q; Shen Y; Ge J
    Wei Sheng Wu Xue Bao; 2014 Apr; 54(4):455-62. PubMed ID: 25007659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Codon-optimization of the hemagglutinin gene from the novel swine origin H1N1 influenza virus has differential effects on CD4(+) T-cell responses and immune effector mechanisms following DNA electroporation in mice.
    Tenbusch M; Grunwald T; Niezold T; Storcksdieck Genannt Bonsmann M; Hannaman D; Norley S; Uberla K
    Vaccine; 2010 Apr; 28(19):3273-7. PubMed ID: 20206668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza.
    Huber VC; McKeon RM; Brackin MN; Miller LA; Keating R; Brown SA; Makarova N; Perez DR; Macdonald GH; McCullers JA
    Clin Vaccine Immunol; 2006 Sep; 13(9):981-90. PubMed ID: 16960108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective efficacy of a human endogenous retrovirus envelope-coated, nonreplicable, baculovirus-based hemagglutin vaccine against pandemic influenza H1N1 2009.
    Choi JY; Gwon YD; Kim JK; Cho YD; Heo YK; Cho HS; Choi TJ; Poo HR; Oh YK; Kim YB
    PLoS One; 2013; 8(11):e80762. PubMed ID: 24260476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.
    Patel A; Gray M; Li Y; Kobasa D; Yao X; Kobinger GP
    Vaccine; 2012 Jan; 30(3):626-36. PubMed ID: 22119588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Study on the immunogenicity of adeno-vector vaccine against H5N1 influenza A virus].
    Zhang XG; Li KB; Ma J; Wang NF; Zhang XM; Sang YH; Dong J; Xu H; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):97-9. PubMed ID: 20104746
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunogenicity and protective efficacy of a DNA vaccine encoding a chimeric protein of avian influenza hemagglutinin subtype H5 fused to CD154 (CD40L) in Pekin ducks.
    Yao Q; Fischer KP; Li L; Agrawal B; Berhane Y; Tyrrell DL; Gutfreund KS; Pasick J
    Vaccine; 2010 Nov; 28(51):8147-56. PubMed ID: 20937323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.
    Wang S; Taaffe J; Parker C; Solórzano A; Cao H; García-Sastre A; Lu S
    J Virol; 2006 Dec; 80(23):11628-37. PubMed ID: 16987975
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protective immunity elicited by a pseudotyped baculovirus-mediated bivalent H5N1 influenza vaccine.
    Wu Q; Xiao S; Fan H; Li Y; Xu J; Li Z; Lu W; Su X; Zou W; Jin M; Chen H; Fang L
    Antiviral Res; 2011 Dec; 92(3):493-6. PubMed ID: 22020305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine.
    Vander Veen RL; Loynachan AT; Mogler MA; Russell BJ; Harris DL; Kamrud KI
    Vaccine; 2012 Mar; 30(11):1944-50. PubMed ID: 22269873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge.
    Ross TM; Xu Y; Bright RA; Robinson HL
    Nat Immunol; 2000 Aug; 1(2):127-31. PubMed ID: 11248804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo electroporation enhances immunogenicity and protection against influenza A virus challenge of an M2e-HSP70c DNA vaccine.
    Jazi MH; Dabaghian M; Tebianian M; Gharagozlou MJ; Ebrahimi SM
    Virus Res; 2012 Aug; 167(2):219-25. PubMed ID: 22609252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platycodin d improves the immunogenicity of newcastle disease virus-based recombinant avian influenza vaccine in mice.
    Xie Y; Sun HX; Li D
    Chem Biodivers; 2010 Mar; 7(3):677-89. PubMed ID: 20232336
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term maintenance of B cell immunity to influenza virus hemagglutinin in mice following DNA-based immunization.
    Justewicz DM; Webster RG
    Virology; 1996 Oct; 224(1):10-7. PubMed ID: 8862394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of DNA-raised immune responses by cotransfected interferon regulatory factors.
    Sasaki S; Amara RR; Yeow WS; Pitha PM; Robinson HL
    J Virol; 2002 Jul; 76(13):6652-9. PubMed ID: 12050378
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles.
    Saluja V; Visser MR; Ter Veer W; van Roosmalen ML; Leenhouts K; Hinrichs WL; Huckriede A; Frijlink HW
    Vaccine; 2010 Nov; 28(50):7963-9. PubMed ID: 20946860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.